EGFR and non-small cell lung carcinoma: Due to the presence of T790M, H1975 cells are highly resistant to EGFR and c-Met TKIs, as seen by higher IC50 for erlotinib and SU11274, compared to EGFR wild-type NSCLC cells [17].